C07D

Heterocyclic Compounds (Drug Molecules)

EPO Patent Bulletin

← All categories
Filter: All Correction Grant Limitation Publication Search Report

86 items

(filtered)
Publication

Process For The Preparation Of Tovorafenib

EP2026028053A2 · Mar 18, 2026
Publication

Improved Synthesis Of Kras G12 C Inhibitor Compound

EP4700030A2 · AMGEN, INC. · Mar 18, 2026
Publication

A Process For Preparing 4 Methyl 2 Propan 2 Yl Pyridine 3 Carbonitrile

EP4711357A2 · AMGEN, INC. · Mar 18, 2026
Publication

Pharmaceutical Agent For Treating Amyotrophic Lateral Sclerosis Or Suppressing Disease Progress Thereof

EP4700016A2 · Tanabe Pharma Corporation · Mar 18, 2026
Publication

Solid State Forms Of Asciminib And Processes For The Preparation Thereof

EP4691464A2 · TAPI Czech Industries s.r.o. · Mar 18, 2026
Publication

Prostaglandin Ep4 Receptor Antagonist Compounds

EP4692085A2 · Nxera Pharma UK Limited · Mar 18, 2026
Publication

Onium Salt, Chemically Amplified Positive Resist Composition And Resist Pattern Forming Process

EP4703795A2 · Shin-Etsu Chemical Co., Ltd. · Mar 18, 2026
Publication

Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases

EP4682148A2 · AbbVie Ireland Unlimited Company · Mar 18, 2026
Publication

Salts And Prodrugs Of 1 Methyl D Tryptophan

EP4659747A2 · Lumos Pharma, Inc. · Mar 18, 2026
Publication

Anti C Met Antibody Drug Conjugates

EP4656248A2 · AbbVie Manufacturing Management Unlimited Company · Mar 18, 2026
Publication

Protein Degraders And Uses Thereof

EP4624467A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Method Of Synthesizing Thyroid Hormone Analogs And Polymorphs Thereof

EP4691557A2 · Madrigal Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4620470A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4613773A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Heteroalkyl Dihydroquinoline Sulfonamide Compounds

EP4595965A2 · Amgen Inc. · Mar 18, 2026
Publication

Methods For Array Synthesis

EP4556467A2 · Vibrant Holdings, LLC · Mar 18, 2026
Publication

Somatostatin Modulators And Uses Thereof

EP4548974A2 · Crinetics Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Improved Process For Preparation Of Apalutamide

EP4541786A2 · Synthon B.V. · Mar 18, 2026
Publication

Combinations Of Nanoparticle Loaded Immune Agonists And Ras Targeted Therapies For Treatment Of Cancer

EP4709736A2 · University of Massachusetts · Mar 18, 2026
Publication

Combination Therapy For Treatment Of Cancer

EP4709384A2 · PMV Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Identification Of Host Factors And Compounds To Boost Viral Transduction

EP4709713A2 · University of Massachusetts · Mar 18, 2026
Publication

Lipids And Lipid Like Compounds For Therapeutic Lipid Nanoparticle (Lnp) Delivery

EP4687854A2 · Sepia Therapeutics, Inc. · Mar 18, 2026
Publication

Compositions For Modulation Of Il 2 And Methods Thereof

EP2024197238A2 · Mar 18, 2026
Publication

Sigma 1 Receptor Ligands And Use Thereof

EP2024196828A2 · Mar 18, 2026
Publication

Compounds And Constructs Useful For Targeting Fibroblast Activation Protein

EP2024196698A2 · Mar 18, 2026
Publication

Compounds And Constructs Useful For Targeting Fibroblast Activation Protein

EP2024196697A2 · Mar 18, 2026
Publication

Solid Forms Of Mdm2 Degraders

EP2024197221A2 · Mar 18, 2026
Publication

Deuterated Mdm2 Degraders And Uses Thereof

EP2024197218A2 · Mar 18, 2026
Publication

Mdm2 Degraders And Uses Thereof

EP2024197216A2 · Mar 18, 2026
Publication

Arginine Vasopressin Receptor (Avpr) Antagonists And Methods Of Using Thereof

EP2024197124A2 · Mar 18, 2026
Publication

Sulfonium Compounds And Methods For Making And Using The Same

EP2024196978A2 · Mar 18, 2026
Publication

Compounds For Restoring Susceptibility To Beta Lactam Antibiotics

EP2024196958A2 · Mar 18, 2026
Publication

Sulfine Based Compounds For Generating Hydrogen Persulfide

EP2024192321A2 · Mar 18, 2026
Publication

3 Alkylamine Indole Activators Of Serotonin Receptors

EP4680236A2 · ATAI Therapeutics, Inc. · Mar 18, 2026
Publication

Compounds, Compositions, And Methods For Treating, Ameliorating, And/Or Preventing Pain

EP2024173873A2 · Mebias Discovery, Inc. · Mar 18, 2026
Publication

Polymorphic Forms And Formulations Of Leriglitazone

EP4709476A2 · Minoryx Therapeutics S.L. · Mar 18, 2026
Publication

Assays For Diagnosing And Evaluating Treatment Options For Fabry Disease

EP4541418A2 · Amicus Therapeutics, Inc. · Mar 18, 2026
Publication

Kinase Inhibitors For The Treatment Of Central And Peripheral Nervous System Disorders

EP4574153A2 · University of Miami · Mar 18, 2026
Publication

Compounds That Participate In Cooperative Binding And Uses Thereof

EP4545521A2 · Revolution Medicines, Inc. · Mar 18, 2026
Publication

Ikaros Zinc Finger Family Degraders And Uses Thereof

EP4464703A2 · Gilead Sciences, Inc. · Mar 18, 2026
Publication

Use Of Compounds For Treating Hk2 Expressing Cancers

EP4464334A2 · VIDAC Pharma Ltd. · Mar 18, 2026
Publication

Rho Kinase Inhibitor Ba 1049 (R) And Active Metabolites Thereof

EP4509138A2 · BioAxone BioSciences, Inc. · Mar 18, 2026
Publication

Substituted Heterocyclic Compounds And Therapeutic Uses Thereof

EP4509122A2 · Bayer Aktiengesellschaft · Mar 18, 2026
Publication

N (Phenyl) 5 (Heteroaryl) 1 H Pyrazol 3 Amine Derivatives As Tnik Inhibitors For Use In The Treatment Of Cancer

EP4477271A2 · Korea Research Institute of Chemical Technology · Mar 18, 2026
Publication

Synthesis Of Cantharidin

EP4339199A2 · Verrica Pharmaceuticals Inc. · Mar 18, 2026
Publication

Adenosine Receptor Antagonists And Uses Thereof

EP4364727A2 · Teon Therapeutics, Inc. · Mar 18, 2026
Publication

Tyk2 Inhibitors And Uses Thereof

EP4438117A2 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Choline Salt Forms Of An Hiv Capsid Inhibitor

EP4382105A2 · Gilead Sciences, Inc. · Mar 18, 2026
Publication

Cdk2 Inhibitors And Uses Thereof

EP4573094A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Carbonic Anhydrase Enzyme Inhibitors And Methods Of Use Thereof

EP4630401A2 · Rutgers, the State University of New Jersey · Mar 18, 2026
Publication

Indolizine Compounds For The Treatment Of Mental Disorders Or Inflammation

EP4499058A2 · Tactogen Inc. · Mar 18, 2026
Publication

Methods And Compositions For Modulating Kras(g12 D)

EP2024044334A2 · Ranok Therapeutics (Hangzhou) Co. Ltd. · Mar 18, 2026
Publication

Organic Compounds

EP4493559A2 · Intra-Cellular Therapies, Inc. · Mar 18, 2026
Publication

Organic Compounds

EP4493560A2 · Intra-Cellular Therapies, Inc. · Mar 18, 2026
Publication

Lrrk2 Inhibitors

EP4504722A2 · Brenig Therapeutics, Inc. · Mar 18, 2026
Publication

Non Aromatic Cyclic Pyrimidine Analogs As Glucosylceramide Synthase Inhibitors

EP4490148A2 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Modified Amino Acids And Uses Thereof

EP4543901A2 · University of Strathclyde · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4472967A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Bicyclic Amides And Esters For Controlling Invertebrate Pests

EP2023097341A2 · Mar 18, 2026
Publication

Solid Forms Of Ceftolozane

EP4327828A2 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Compounds With An Acceptor And A Donor Group

EP4271163A2 · Merck Patent GmbH · Mar 18, 2026
Publication

Crystalline Forms Of N (4 (4 (Cyclopropylmethyl) Piperazine 1 Carbonyl)phenyl)quinoline 8 Sulfonamide

EP4285904A2 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Substituted 4 Aminoisoindoline 1,3 Dione Compounds And Processes For Their Preparation

EP4272737A2 · Celgene Corporation · Mar 18, 2026
Publication

Synthesis Method Of Furoimidazopyridine Compound, Crystal Form Of Furoimidazopyridine Compound, And Crystal Form Of Salt Thereof

EP4248967A2 · Hangzhou Highlightll Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Synthesis Method Of Furoimidazopyridine Compound, Crystal Form Of Furoimidazopyridine Compound, And Crystal Form Of Salt Thereof

EP4248966A2 · Hangzhou Highlightll Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Crystalline Forms Of (2 R,5 S,13 Ar) 8 Hydroxy 7,9 Dioxo N (2,4,6 Trifluorobenzyl) 2,3,4,5,7,9,13,13 A Octahydro 2,5 Methanopyrido [1',2':4,5]Pyrazino [2,1 B][1,3]Oxazepine 10 Carboxamide

EP4309736A2 · Gilead Sciences, Inc. · Mar 18, 2026
Publication

Azolopyrimidine For The Treatment Of Cancer Related Disorders

EP4310082A2 · Arcus Biosciences, Inc. · Mar 18, 2026
Publication

Alkyl Chain Modified Imidazoquinoline Derivatives As Tlr7/8 Agonists And Uses Thereof

EP4257198A2 · Dynavax Technologies Corporation · Mar 18, 2026
Publication

Organotin Catalysts In Esterification Processes Of Furan 2,5 Dicarboxylic Acid (Fdca)

EP4253370A2 · Archer Daniels Midland Company · Mar 18, 2026
Publication

Compositions And Methods For Diagnosis, Treatment Of And Prevention Of Kidney Disease

EP4453235A2 · XORTX Therapeutics Inc. · Mar 18, 2026
Publication

Bcat2 Inhibitors

EP4430036A2 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Inhibitors Of Menin Mll Interaction

EP4444300A2 · Bala Therapeutics, Inc. · Mar 18, 2026
Publication

Bifunctional Chimeric Molecules For Labeling Of Kinases With Target Binding Moieties And Methods Of Use Thereof

EP4433458A2 · The Broad Institute, Inc. · Mar 18, 2026
Publication

Methods For The Production Of Tryptophans, Tryptamines, Intermediates, Side Products And Derivatives

EP4426676A2 · MIAMI UNIVERSITY · Mar 18, 2026
Publication

Bifunctional Molecules For Selective Modification Of Target Substrates

EP4320126A2 · The Broad Institute, Inc. · Mar 18, 2026
Publication

Heteroaryl Derivatives As Pd1/Pd L1 Inhibitors For The Treatment Of Hbv And Cancer

EP4313968A2 · Arbutus Biopharma Corporation · Mar 18, 2026
Publication

Artemisinin Proteasome Inhibitor Conjugates And Their Use In The Treatment Of Disease

EP4281066A2 · Cornell University · Mar 18, 2026
Publication

Compositions And Methods For Enhancing Anti Viral Therapies

EP4301355A2 · XORTX Therapeutics Inc. · Mar 18, 2026
Publication

Heterocyclic Compounds As Ret Kinase Inhibitors

EP4104837A2 · Cancer Research Technology Limited · Mar 18, 2026
Publication

Rho Kinase Inhibitors

EP4116293A2 · Kadmon Corporation, LLC · Mar 18, 2026
Publication

Bicyclic Kinase Inhibitors And Uses Thereof

EP4143191A2 · iOmx Therapeutics AG · Mar 18, 2026
Publication

Regioselective Oxidation Of Heterocyclic Alpha Amino Amides

EP4139283A2 · PharmaZell GmbH · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4076524A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Inhibitors Of Cytochrome P450 Family 7 Subfamily B Member 1 (Cyp7 B1) For Use In Treating Diseases

EP3558304A2 · Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) · Mar 18, 2026
Publication

Commercially Viable Synthesis Of Cantharidin And Bioactive Cantharidin Derivatives

EP3233865A2 · Verrica Pharmaceuticals Inc. · Mar 18, 2026
Publication

Method For Modifying The Surface Composition Of Alpha Alumina

EP2620212A2 · Dow Global Technologies LLC · Mar 18, 2026